SCHEMBL4141122

SCHEMBL4141122

NCCCCNS(=O)(=O)c1ccc(F)cc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 0.56
CYP1A2 P05177 7/20 0.56
CYP2C9 P11712 7/20 0.56
CYP2C19 P33261 7/20 0.56
TP53 P04637 6/20 0.56
CYP2D6 P10635 6/20 0.56
MAPK1 P28482 3/20 0.56
THPO P40225 3/20 0.56
NFKB1 P19838 2/20 0.56
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
ALDH1A1 P00352 4/20 0.54
PMP22 Q01453 3/20 0.54
NPSR1 Q6W5P4 3/20 0.54
TSHR P16473 2/20 0.54
GMNN O75496 2/20 0.54
LMNA P02545 2/20 0.54
FPR2 P25090 2/20 0.54
TDP1 Q9NUW8 1/20 0.54
MAPT P10636 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14360846 0.96 CCR1 (0.52) CYP3A4CYP1A2CYP2C9CYP2C19TP53
SCHEMBL7010992 0.85 MEN1 (0.53) CYP3A4CYP1A2CYP2C9CYP2C19TP53
SCHEMBL4128136 0.85 CYP3A4 (0.58) CYP3A4CYP1A2CYP2C9CYP2C19TP53
SCHEMBL7005708 0.85 MEN1 (0.53) CYP3A4CYP1A2CYP2C9CYP2C19TP53
SCHEMBL4136570 0.79 TRPV4 (0.49) CCR1TDO2TRPV4
SCHEMBL2010514 0.76 ALOX5AP (0.48) MEN1KMT2AALDH1A1LMNACCR1
SCHEMBL5441643 0.76 CNR2 (0.48) CYP3A4CYP1A2CYP2C9CYP2C19TP53
SCHEMBL7213002 0.76 ACLY (0.49) ALDH1A1FABP4
SCHEMBL4140295 0.76 BMP1 (0.51) CCR1TRPV4CNR1CNR2FABP4
SCHEMBL5447807 0.75 GBA1 (0.59) ALDH1A1CCR1PKMTDO2TRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105259-A1 Acyclic 1,4-Diamines and Uses Thereof SMITHKLINE BEECHAM CORPORATION 2009-04-23 US disclosed
US-20090105259-A1 Acyclic 1,4-Diamines and Uses Thereof SMITHKLINE BEECHAM CORPORATION 2009-04-23 US disclosed
US-20090105259-A1 Acyclic 1,4-Diamines and Uses Thereof SMITHKLINE BEECHAM CORPORATION 2009-04-23 US disclosed
WO-2007030761-A2 ACYCLIC 1,4-DIAMINES AND USES THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105259-A1 Acyclic 1,4-Diamines and Uses Thereof TRPV4, TRPC4, TRPV1 CYP3A4 1672/4885CYP1A2 3159/4885CYP2C9 3459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.